21 research outputs found
Constraints on the shallow elastic and anelastic structure of Mars from InSight seismic data
Marsâs seismic activity and noise have been monitored since January 2019 by the seismometer of the InSight (Interior Exploration using Seismic Investigations, Geodesy and Heat Transport) lander. At night, Mars is extremely quiet; seismic noise is about 500 times lower than Earthâs microseismic noise at periods between 4 s and 30 s. The recorded seismic noise increases during the day due to ground deformations induced by convective atmospheric vortices and ground-transferred wind-generated
lander noise. Here we constrain properties of the crust beneath InSight, using signals from atmospheric vortices and from the
hammering of InSightâs Heat Flow and Physical Properties (HP3) instrument, as well as the three largest Marsquakes detected
as of September 2019. From receiver function analysis, we infer that the uppermost 8â11 km of the crust is highly altered and/
or fractured. We measure the crustal diffusivity and intrinsic attenuation using multiscattering analysis and find that seismic
attenuation is about three times larger than on the Moon, which suggests that the crust contains small amounts of volatiles
SEIS: Insightâs Seismic Experiment for Internal Structure of Mars
By the end of 2018, 42 years after the landing of the two Viking seismometers
on Mars, InSight will deploy onto Marsâ surface the SEIS (Seismic Experiment for Internal
Structure) instrument; a six-axes seismometer equipped with both a long-period three-axes
Very Broad Band (VBB) instrument and a three-axes short-period (SP) instrument. These
six sensors will cover a broad range of the seismic bandwidth, from 0.01 Hz to 50 Hz,
with possible extension to longer periods. Data will be transmitted in the form of three
continuous VBB components at 2 sample per second (sps), an estimation of the short period
energy content from the SP at 1 sps and a continuous compound VBB/SP vertical axis at
10 sps. The continuous streams will be augmented by requested event data with sample
rates from 20 to 100 sps. SEIS will improve upon the existing resolution of Vikingâs Mars
seismic monitoring by a factor of ⌠2500 at 1 Hz and ⌠200 000 at 0.1 Hz. An additional
major improvement is that, contrary to Viking, the seismometers will be deployed via a
robotic arm directly onto Marsâ surface and will be protected against temperature and wind
by highly efficient thermal and wind shielding. Based on existing knowledge of Mars, it is
reasonable to infer a moment magnitude detection threshold of Mw ⌠3 at 40⊠epicentral
distance and a potential to detect several tens of quakes and about five impacts per year. In
this paper, we first describe the science goals of the experiment and the rationale used to
define its requirements. We then provide a detailed description of the hardware, from the
sensors to the deployment system and associated performance, including transfer functions
of the seismic sensors and temperature sensors. We conclude by describing the experiment
ground segment, including data processing services, outreach and education networks and
provide a description of the format to be used for future data distribution
CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy
Spinal muscular atrophy (SMA) is a neuromuscular disease caused by a deficiency of survival motor neuron (SMN) due to mutations in the SMN1 gene. In this study, an adeno-associated virus (AAV) vector expressing human SMN (AAV8-hSMN) was injected at birth into the CNS of mice modeling SMA. Western blot analysis showed that these injections resulted in widespread expression of SMN throughout the spinal cord, and this translated into robust improvement in skeletal muscle physiology, including increased myofiber size and improved neuromuscular junction architecture. Treated mice also displayed substantial improvements on behavioral tests of muscle strength, coordination, and locomotion, indicating that the neuromuscular junction was functional. Treatment with AAV8-hSMN increased the median life span of mice with SMA-like disease to 50 days compared with 15 days for untreated controls. Moreover, injecting mice with SMA-like disease with a human SMNâexpressing self-complementary AAV vector â a vector that leads to earlier onset of gene expression compared with standard AAV vectors â led to improved efficacy of gene therapy, including a substantial extension in median survival to 157 days. These data indicate that CNS-directed, AAV-mediated SMN augmentation is highly efficacious in addressing both neuronal and muscular pathologies in a severe mouse model of SMA
Reversible cardiac fibrosis and heart failure induced by conditional expression of an antisense mRNA of the mineralocorticoid receptor in cardiomyocytes
Cardiac failure is a common feature in the evolution of cardiac disease. Among the determinants of cardiac failure, the reninâangiotensinâaldosterone system has a central role, and antagonism of the mineralocorticoid receptor (MR) has been proposed as a therapeutic strategy. In this study, we questioned the role of the MR, not of aldosterone, on heart function, using an inducible and cardiac-specific transgenic mouse model. We have generated a conditional knock-down model by expressing solely in the heart an antisense mRNA directed against the murine MR, a transcription factor with unknown targets in cardiomyocytes. Within 2â3 mo, mice developed severe heart failure and cardiac fibrosis in the absence of hypertension or chronic hyperaldosteronism. Moreover, cardiac failure and fibrosis were fully reversible when MR antisense mRNA expression was subsequently suppressed